focus -WSS

focus

author：Wikipedia 2025-09-27 22:05:50 - browse：1

Sen. Bill Cassidy, R-La., listens during a Senate Health, Education, Labor, and Pensions Committee hearing. -- health policy coverage from STAT — Sen. Bill Cassidy (R-La.) Stefani Reynolds/The New York Times via AP

WASHINGTON — The top-ranking Republican on the Senate health committee is launching an investigation into two hospitals’ use of a government program that provides big drug discounts in return for serving low-income communities.

At the foundation of the debate over the so-called 340B program is whether Congress intended it to directly benefit low-income and uninsured patients or whether it was meant to help finance those hospitals, which could use the money as they see fit to add services.

Hospitals say they use the money to provide such services as free care for uninsured patients, free vaccinations, mental health clinics, and community health programs. But drugmakers have long argued that hospitals and chain pharmacies abuse the program and divert its cash flows to other uses. They also say the 340B program fuels the consolidation of health care systems as hospitals buy up private doctor practices to expand the 340B revenue stream.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： California Joshua trees severely burned in massive wildfire

focus

WSS

Pediatricians' group reaffirms support for gender

US Marines prepare to be put on commercial ships to deter Iranian harassment in Strait of Hormuz

In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati

Jailed Russian opposition leader Alexey Navalny gets 19 more years in prison

Colorectal cancer study finds potential in overlooked immune cell

FDA panel signals lack of confidence in Amgen cancer drug data

hotspot

focus

focus

Trump demands the U.S. pay no more for drugs than other countries … again

New company forms to vet health AI models, root out weaknesses

BioMarin wins approval for gene therapy to treat hemophilia A

Rock icon Freddie Mercury pre

How one medical school became remarkably diverse

3 questions for the future of Biden's cancer moonshot

What does generative AI mean for health care? We asked experts

FDA panel signals lack of confidence in Amgen cancer drug data

In age of alternative facts, a scholarly course on calling out crap

Histogen: Failed biotech offers rare public look inside

focus

FDA panel signals lack of confidence in Amgen cancer drug data

Medical mystery: When an infection after surgery isn’t what it seems

Judge in Trump's Jan. 6 case gives attorneys 2 weeks to propose trial date

Why age limits for politicians are a terrible idea

Jesse Tyler Ferguson makes friendship bracelets for Taylor Swift's Eras Tour

Slain Parkland victim's father speaks out following reenactment

entertainment

focus

leisure time

leisure time